Download Files:
Products Details
Product Description
– Cap-dependent endonuclease-IN-1 is an orally active cap-dependent endonuclease inhibitor with high potency. Cap-dependent endonuclease-IN-1 can be used for the research of influenza[1][2].
Web ID
– HY-132894
Shipping
– Room temperature
Applications
– COVID-19-immunoregulation
Molecular Formula
– C27H22F2N2O6S
References
– [1]Ming-Chu Hsu, et al. Cap-dependent endonuclease inhibitors. Patent WO2019144089A1. |[2]Chi-Feng Yen, et al. Amorphous solid dispersion formulation. Patent US20220202817A1.
CAS Number
– 2365473-17-0
Molecular Weight
– 540.54
SMILES
– O=C1C2(CC2)CN([C@@]3([H])C4=CC=C(F)C(F)=C4CSC5=CC=CC=C53)N6C1=C(C(C=C6)=O)OCOC(OC)=O
Clinical Information
– No Development Reported
Research Area
– Infection
Solubility
– 10 mM in DMSO
Target
– Influenza Virus
Pathway
– Anti-infection
Product type
– Reference compound
Disclaimer: All products are for Research use only unless clearly stated otherwise on the product datasheet. Datasheets provided on the website are drafts for reference purpose only and you are requested to always refer to the hard copy included in the kit for your experimentation. Agdia Products are available for delivery only in Canada.
